February 24, 2021 – Therapeutics, a Cambridge, Mass.-based biotechnology company dedicated to designing and delivering a new class of fully engineered circular RNA therapeutics (oRNAs), completed an $80m Series A financing.
February 24, 2021 – Therapeutics, a Cambridge, Mass.-based biotechnology company dedicated to designing and delivering a new class of fully engineered circular RNA therapeutics (oRNAs), completed an $80m Series A financing.